Cilostazol Following Peripheral Endovascular Procedures
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.
Also called NCT02770274
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 200 participants
- Registry
-
NCT02770274
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Greece
- Registry status
- Unknown status
Technical summary
Registry record NCT02770274. Randomized; single masking; primary purpose prevention. Start 2016-12 (actual); primary completion 2021-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Cilostazol Following Peripheral Endovascular Procedures
- Acronym
- CILO-PER
- Condition
- Peripheral Arterial Disease
- Intervention (Drug)
- Cilostazol
- Intervention (Drug)
- Aspirin
- Lead sponsor
- Attikon Hospital
- Collaborator
- University Hospital of Patras
Record details
- Record id
cardio:ct-nct02770274- Content hash
ec1eb5496dbda4ceafab153470090c2690e2c23563fcbf35ca32c95f7eef9899